The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as possible dangers.
Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.
GLP-1 drugs like Ozempic and Zepbound treat diseases related to blood sugar and weight management. Professor Joe Balagtas ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
11d
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback